Barrow Hanley Mewhinney & Strauss LLC Haemonetics Corp Transaction History
Barrow Hanley Mewhinney & Strauss LLC
- $28.2 Billion
- Q2 2025
A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 480,834 shares of HAE stock, worth $25.1 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
480,834Holding current value
$25.1 Million% of portfolio
0.13%Shares
6 transactions
Others Institutions Holding HAE
# of Institutions
336Shares Held
53.3MCall Options Held
541KPut Options Held
309K-
Black Rock Inc. New York, NY5.96MShares$311 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$259 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.28MShares$223 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA2.15MShares$112 Million0.03% of portfolio
-
State Street Corp Boston, MA1.88MShares$98.4 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.68B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...